CK
Colleen Kusy Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
30%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
64.3%
Neutral
35.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $858 |
8%
upside
| 1 | – |
–
| 18 Dec ‘25 21 days ago |
|
|
|
Outperform
Maintained
| $158 |
54%
upside
| 2 | +18% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $34 |
4%
downside
| 1 | – |
–
| 11 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $52 |
98%
upside
| 3 | +14% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $24 |
111%
upside
| 1 | +2.9% |
0
%
| 3 Oct ‘25 3 months ago |
|
|
|
Outperform
Initiated
| $9 |
97%
upside
| 1 | +166% |
0
%
| 15 Aug ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $52 |
124%
upside
| 1 | +6.1% |
0
%
| 16 Jun ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $6 |
60%
upside
| 3 | – |
–
| 4 Jun ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $41 |
86%
upside
| 1 | +17% |
0
%
| 13 Mar ‘25 10 months ago |
|